View Cart (0 items)

Bristol-Myers, Simcere Sign Development Deal

November 04, 2010
/ Print / Reprints /
| Share More
/ Text Size+
The Associated Press reports, Bristol-Myers Squibb Co. and Simcere Pharmaceutical Group said they will develop a potential cancer treatment. Under the deal, the companies will develop BMS-817378, which is still in the laboratory stage of development. Simcere, based in China, receives exclusive rights to develop and sell the product in China while New York-based Bristol-Myers Squibb retains exclusive rights in all other markets. Financial details of the deal were not disclosed.

Click here for more Industry News...

You must login or register in order to post a comment.